TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
99,07 BRL
arrow_upward
+1,33%(+1,30) 1 д.
28.09, 20:23:55 ч. Гринуич-3 · BRL
search
Всички символи
| Символ | Цена | Промяна | % промяна |
|---|
insights_autoГенерира се водещата статистика за TAKP34…
Пазарна кап.
57,21 млрд.
Ср. обем
36,00
Обем
0,00
Най-висока цена за 52 седм.
99,07 BRL
Най-ниска цена за 52 седм.
70,80 BRL
Акции в обращение
1,60 млрд.
Брой служители
47 хил.
Пазарна кап.
57,21 млрд.
Ср. обем
36,00
Обем
0,00
Най-висока цена за 52 седм.
99,07 BRL
Най-ниска цена за 52 седм.
70,80 BRL
Акции в обращение
1,60 млрд.
Брой служители
47 хил.
Новинарски материали
От източници в мрежата и новинарски партньори
TipRanks
·
преди 1 час
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
Stock Traders Daily
·
преди 1 ден
(TAK) Movement Within Algorithmic Entry Frameworks
Профил
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Всичко за Takeda Pharmaceutical Co Ltd BDR
Главен изпълнителен директорКристоф Вебер | Кристоф Вебер
Служители47 хил.
Дата на основаване12.06.1781 г.
Централен офис-
Бранш-
Уебсайтtakeda.com